APPLICATION
ANDA215397
TYPE
ANDA
ORIGINAL APPROVAL
2023-06-07
LATEST ACTION
2025-03-13
ROUTE
INTRAMUSCULAR, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
MEDROXYPROGESTERONE ACETATEPrescription
MEDROXYPROGESTERONE ACETATE 150MG/ML · INJECTABLE · INJECTION
Approval history
2025-03-13Labeling · Supplement 5 · standardAP
2023-06-07UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.